CRF Creator Fact Sheet | Certara
Learn how Pinnacle 21 CRF Creator streamlines CRF design and build, enabling more efficient study setup with built-in quality and compliance.| Certara
[event_date_range] The post in silico Safety and Toxicology assessment: ToxStudio® appeared first on Certara.| Certara
[event_date_range] The post PopSim Symposium Quantitative Systems Pharmacology appeared first on Certara.| Certara
Certara supports public radio because NPR is aligned with our values and helps us spread our message of Transforming Drug Discovery and Development for Good. The post At Certara, we’re proud to support NPR appeared first on Certara.| Certara
Learn how Pinnacle 21 CRF Creator streamlines CRF design and build, enabling more efficient study setup with built-in quality and compliance.| Certara
Automate SDTM data transformation with Pinnacle 21 Enterprise Plus mapping specification software, and automatically comply with CDISC standards. The post Pinnacle 21 Enterprise Plus: Your Route to Faster, Compliant SDTM Mapping Specs appeared first on Certara.| Certara
Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide safer, more effective drug development decisions. The post Key Lessons & Opportunities in applying NCA and PopPK to ADCs appeared first on Certara.| Certara
This blog explains what GPTs are, why using ChatGPT for life sciences isn’t ideal, and how Certara.AI can accelerate drug development.| Certara
AI prompt engineering is an essential skill for using LLMs. Read our blog for best practice methods on AI prompt engineering and AI prompting techniques. The post Best Practices for AI Prompt Engineering in Life Sciences in 2025 appeared first on Certara.| Certara
QSP modeling holds huge promise, but complexity and scalability limit adoption. We review the challenges & path toward broader impact in drug development. The post Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling appeared first on Certara.| Certara
Certara’s Karen Yeo discusses FDA’s draft guidance to include pregnant and breastfeeding women in clinical trials and how modeling supports safer dosing.| Certara
Learn how tailored AI solutions streamline regulatory writing, boosting efficiency, accuracy, & compliance. Download the white paper!| Certara
Increase the efficiency of regulatory and medical writing with Certara’s purpose-built Generative AI-Enabled Writing Software.| Certara
The website from which you got to this page is protected by Cloudflare. Email addresses on that page have been hidden in order to keep them from being accessed by malicious bots. You must enable Javascript in your browser in order to decode the e-mail address.| www.certara.com
Certara introduces Libra™, an AI-powered tool within ToxStudio® to predict drug-induced liver injury (DILI) early in discovery. Using QSAR modeling, Bayesian analytics, and automated reporting, Libra helps researchers improve drug safety, reduce late-stage failures, and align with FDA’s 2025 roadmap on New Approach Methodologies.| Certara
Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage DDI risk in clinical trials.| Certara
Join Certara's Fall 2025 Certainty Circuit in EMEA & APAC to explore AI-enabled biosimulation insights, MIDD, and drug discovery trends.| Certara
[event_date_range] The post AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success appeared first on Certara.| Certara
Certara joins the Veeva AI Partner Program to integrate CoAuthor™ generative AI with Veeva RIM, simplifying medical writing workflows for life sciences organizations.| Certara
Step-by-step framework to evaluate and select patient services partners – define criteria, score vendors, run RFPs, and make a confident, launch-ready decision The post Patient Services Vendor Selection Guide appeared first on Certara.| Certara
Certara celebrates its 200 published papers and 11 scientists ranked in the top 2% of the most-cited researchers in 2025, highlighting leadership in model-informed drug development.| Certara
Discover how Certara IQ uses QSP modeling to predict safe and effective First-In-Human doses, accelerating clinical readiness and regulatory confidence.| Certara
Certara's transformative drug development solutions include data-driven modelling, AI and predictive simulation. Accelerate your development process for good| Certara
The industry's most trusted pharmacokinetics software for non-compartmental analysis (NCA), population PK (popPK), IVIVC, and more. Learn more...| Certara
